Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
Motley Fool Money30 Heinä 2023

Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs

Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey caught up with Winkler to discuss: - The origins and science behind weight loss drugs. - The challenge of selling lizard venom research to pharmaceutical companies. - What decades-old research on anglerfish reveals about modern side effects for Ozempic. - And why it’s “not too hard” to keep dozens of Gila Monsters in your basement. “Monster Diet Drugs Like Ozempic Started With Actual Monsters”: https://www.wsj.com/articles/ozempic-mounjaro-gila-monster-anglerfish-8c9c1ff2 Companies mentioned: NVO, LLY Host: Ricky Mulvey Guest: Rolfe Winkler Engineers: Tim Sparks, Heather Horton Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaksot(2083)

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
ostan-asuntoja-podcast
oppimisen-psykologia
pomojen-suusta
taloudellinen-mielenrauha
rss-lahtijat
sijoituspodi
rss-rahamania
rss-seuraava-potilas
rss-viisas-raha-podi
rss-neuvottelija-sami-miettinen
rahapuhetta
sijoituskaverit
kasvun-kipuja
rss-rikasta-elamaa
rss-turvacast
rss-merja-mahkan-rahat